DDD-028

DDD-028 is a potent non-opioid, non-cannabinoid analgesic which attenuates neuropathic and inflammatory pain without the possible side effects or abuse potential associated with opioid or cannabinoid activities. DDD-028 can be utilized in analgesic research[1].

Product Specifications

CAS Number

[1538586-09-2]

UNSPSC

12352005

Target

Opioid Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/ddd-028.html

Smiles

CN(CC1)CC2=C1N(CC3)C4=C2C=CC=C4C5=C3C=CC=C5

Molecular Formula

C20H20N2

Molecular Weight

288.39

References & Citations

[1]Rajagopalan P, et al. DDD-028: a potent potential non-opioid, non-cannabinoid analgesic for neuropathic and inflammatory pain. Bioorg Med Chem Lett. 2014 Jul 15;24 (14) :3088-91.